Delivery Order 75A50122D00002-75A50126F61020
Award Date 3/13/26
Potential Completion Date 10/29/26
Potential Value $493K
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a delivery order valued at $7.4 million to GlaxoSmithKline, LLC for storage and stability services related to antigens and adjuvants from prior contracts during Base Period Year 3, with performance in Durham, North Carolina. The award was made on February 21, 2024, under Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75A50122D000002, with an ultimate completion date...
- This is a $499,100 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC. The order is for pharmaceutical goods and services under the Pandemic Influenza Preparedness and Response 2016-2021 multiple award contract. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of products to U.S. government agencies including influenza and hepatitis...
- This is a $105,351.10 delivery order contract awarded by the Department of Health and Human Services (HHS) to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, for the supply of vaccines. The contract is not set-aside and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The vaccines will be delivered from Glaxosmithkline's facilities in Research Triangle Park, North Carolina. Glaxosmithkline has a range of federal...
- This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...
- This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
- The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...
- The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a firm fixed-price delivery order valued at $451,455 to GlaxoSmithKline, LLC on April 13, 2020, with completion targeted for May 13, 2020. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not contain a set-aside designation. The work will be performed in Research Triangle Park, North Carolina, where GlaxoSmithKline maintains its primary...
- This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...
- The U.S. Bureau of Administration awarded a $24,928.33 firm fixed-price purchase order to GlaxoSmithKline, LLC for medical supplies on December 8, 2025, with an ultimate completion date of January 2, 2026. The contract, which carries no set-aside designation, will be performed in Durham, North Carolina, where GlaxoSmithKline maintains its headquarters. As a foreign-owned pharmaceutical company, GlaxoSmithKline serves as a prime contractor and supplier of vaccines, antiviral medications, and...
- This federal contract award is for the manufacture of one bulk lot of the antigen AS03 on behalf of the Department of Defense Defense Health Agency. The contract was awarded to Glaxosmithkline, LLC, a pharmaceutical company that has provided a range of pharmaceutical goods and services to U.S. government agencies through various federal contracts and grants. The $8,359,043 firm fixed price delivery order is issued under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite...